Back to Directory
FGF-21 Analogs
Anti-Aging & LongevityFibroblast growth factor 21 analogs being developed for metabolic diseases and weight loss.
Key Benefits
- ✓Weight loss
- ✓Improves glucose metabolism
- ✓Treats fatty liver disease
- ✓Enhances insulin sensitivity
- ✓Reduces triglycerides
- ✓Potential for metabolic diseases
Dosing Information
Dosage Range
Under investigation
Frequency
Weekly to monthly
Typical Duration
Clinical trials ongoing
Detailed Protocol
Multiple analogs in development (pegbelfermin, efruxifermin, others). Administered via subcutaneous injection weekly or monthly depending on formulation. Investigational.
About FGF-21 Analogs
FGF-21 is a hormone involved in glucose and lipid metabolism. Long-acting analogs are being developed for obesity, type 2 diabetes, and NASH. Multiple pharmaceutical companies developing FGF-21-based therapies.
Research Notes
Multiple FGF-21 analogs in phase 2/3 trials for obesity and NASH. Promising results for weight loss and metabolic improvements. Several compounds in development pipeline.
Potential Side Effects
- •Diarrhea in some trials
- •Generally well tolerated
- •Investigational compounds
Always consult with a healthcare professional before starting any peptide therapy.